Edap Tms SA reported FDA clearance of its Ablatherm-Fusion device, a high intensity focused ultrasound (HIFU) technology that enables a method for the targeting of diagnosed areas within the prostate. The FDA's nod for the device comes on the heels of the Centers for Medicare and Medicaid Services (CMS) approval of a new code that could quite possibly lead to an increase in HIFU device adoption.